Interpreters as Advocates for Hypertensive Patients

Interpreters as Advocates for Hispanic Patients With Hypertension

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05219032

Enrollment

Registered

2022-02-01

Start date

2010-04-30

Completion date

2014-01-31

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Hypertension, Spanish

Brief summary

The purpose of the study is to determine if medical interpreters trained to advocate on behalf of their patients deliver improved care compared to standard medical interpreters

Detailed description

Over 21 million Americans have limited English proficiency. About two-thirds of these individuals speak Spanish. Limited English proficiency has major adverse impacts on health and health care. Using trained medical interpreters may help overcome this language barrier. Compared to patients who need but don't get an interpreter, patients who use trained medical interpreters have better satisfaction, quality of care, and health outcomes. However, the outcomes of patients using interpreters is often poorer than that of English-speaking patients. This randomized controlled trial will test the utility of using interpreters as advocates for Spanish-speaking inner city patients with hypertension.

Interventions

BEHAVIORALProfessional Medical Interpreter

A professional medical interpreter accompanies patient to each appointment.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Spanish speaking * Limited English proficiency * Uncontrolled hypertension * Regular visit with primary care provider who is not proficient in Spanish

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Patient reported satisfaction with the clinical encounter with their clinician	6 months	Patients will rate their satisfaction with the clinical encounter with their clinician y responding to several questions about the encounter using a 5-point Likert scale.

Secondary

Measure	Time frame	Description
Provider reported satisfaction with the clinical encounter with the patient	6 months	Providers will rate their satisfaction with the clinical encounter with the patient by responding to several questions about the encounter using a 5-point Likert scale.
Change in systolic and diastolic blood pressure	6 months	Net change in systolic and diastolic blood pressure

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026